Photo taken from Luca Malorni/LinkedIn
Jul 23, 2024, 11:27
Luca Malorni: Our editorial discussing the results of the SERENA-1 trial
Luca Malorni, Director of the Translational Research Unit at AUSL Toscana Centre at Hospital of Prato, shared on X:
“Here’s our editorial in Annals of Oncology discussing the results of the SERENA-1 trial where we share some open questions, including the issue of patients selection for these new endocrine agents.”
Source: Luca Malorni/X
The new oral SERDs in endocrine-resistant breast cancer: who will benefit the most?
Authors: I. Migliaccio, L. Biganzoli, and L. Malorni.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 19:25
Nov 13, 2024, 16:51
Nov 13, 2024, 16:49
Nov 13, 2024, 16:45
Nov 13, 2024, 16:25
Nov 13, 2024, 16:23
Nov 13, 2024, 16:08